Task: Answer the multiple-choice question.
Question: Which drug exhibits a -18.498% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a O=C(CN1C(=O)CCC1=O)Nc1nc2ccc(Br)cc2s1
b COc1ccc2c(c1)OC1(C)CC2C(C(=O)c2ccccc2OC)C(=O)N1
Answer: a. O=C(CN1C(=O)CCC1=O)Nc1nc2ccc(Br)cc2s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CN1C(=O)CCC1=O)Nc1nc2ccc(Br)cc2s1
O=C(CN1C(=O)CCC1=O)Nc1nc2ccc(Br)cc2s1
N-(6-bromo-1,3-benzothiazol-2-yl)-2-(2,5-dioxopyrrolidin-1-yl)acetamide